(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.16%) $0.928
(0.31%) $10.88
(0.00%) $0.792
(0.03%) $92.61
Live Chart Being Loaded With Signals
Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States...
Stats | |
---|---|
Today's Volume | 720 030 |
Average Volume | 1.02M |
Market Cap | 956 000 |
EPS | $0 ( 2024-03-22 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0128 |
ATR14 | $0.116 (114.74%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-18 | Smith Brandon D | Buy | 0 | |
2023-12-15 | Vivo Capital Viii, Llc | Sell | 87 934 | Common Stock |
2023-12-18 | Vivo Capital Viii, Llc | Sell | 209 029 | Common Stock |
2023-12-19 | Vivo Capital Viii, Llc | Sell | 208 657 | Common Stock |
2023-12-15 | Vivo Capital Viii, Llc | Sell | 12 066 | Common Stock |
INSIDER POWER |
---|
47.76 |
Last 95 transactions |
Buy: 8 739 782 | Sell: 5 181 184 |
Volume Correlation
Impel Pharmaceuticals Correlation
10 Most Positive Correlations | |
---|---|
FNWB | 0.921 |
EGBN | 0.909 |
CNSL | 0.904 |
DIBS | 0.901 |
ALTO | 0.896 |
FTXO | 0.892 |
FFIC | 0.885 |
FRST | 0.883 |
CSTE | 0.881 |
CCSI | 0.88 |
10 Most Negative Correlations | |
---|---|
LMNR | -0.937 |
WIRE | -0.927 |
NRDS | -0.918 |
MHUA | -0.893 |
PEGA | -0.892 |
SKYT | -0.889 |
OBT | -0.889 |
MORF | -0.886 |
HTBI | -0.884 |
HUGE | -0.882 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Impel Pharmaceuticals Correlation - Currency/Commodity
Impel Pharmaceuticals Financials
Annual | 2022 |
Revenue: | $12.65M |
Gross Profit: | $6.16M (48.66 %) |
EPS: | $-5.52 |
Q3 | 2023 |
Revenue: | $5.02M |
Gross Profit: | $2.79M (55.60 %) |
EPS: | $-0.580 |
Q2 | 2023 |
Revenue: | $6.58M |
Gross Profit: | $3.36M (51.09 %) |
EPS: | $-0.310 |
Q1 | 2023 |
Revenue: | $4.37M |
Gross Profit: | $2.09M (47.74 %) |
EPS: | $-1.630 |
Financial Reports:
No articles found.
Impel Pharmaceuticals
Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The company is also developing INP105, an upper nasal formulation of olanzapine for the acute treatment of agitation and aggression in autism spectrum disorder; and INP107, an upper nasal formulation of carbidopa/levodopa, which has completed Phase IIa clinical trial for the treatment of OFF episodes in Parkinson's disease. Impel Pharmaceuticals Inc. was formerly known as Impel NeuroPharma, Inc. and changed its name to Impel Pharmaceuticals Inc. in April 2022. Impel Pharmaceuticals Inc. was incorporated in 2008 and is headquartered in Seattle, Washington.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators